During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...

Precursor B-cell acute lymphoblastic leukemia is a fast-growing leukemia that affects early B cells in bone marrow. It’s both more common and has a better outlook in children. Leukemia is a type ...

Venetoclax, a selective Bcl-2 inhibitor, has proven effective in chronic lymphocytic leukemia (CLL), but genetic mutations or ...

Chronic lymphocytic leukemia (CLL) is usually a slow-growing blood cancer. Most people with CLL don’t notice any problems in the early stages of the disease. “In fact, we can do what we call ...

Multiple steps are involved in the pathogenesis of chronic lymphocytic leukemia (CLL) and various factors are related to its development: cytogenetic aberrations, antigenic triggers activated by ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Patients with coexisting conditions or who have poor outcomes with standard therapy—a large majority of which are older adults—struggle with standard treatments for chronic and small lymphocytic ...

Chronic myeloid leukemia (CML) The word "myeloid" also refers to a group of cells that differentiate, or mature, from a common myeloid progenitor cell type. The myeloid term also includes these ...

About 23,690 new cases of CLL (14,340 in males and 9,350 in females) About 4,460 deaths from CLL ( 2,810 in males and 1,650 in females) CLL accounts for about 1 in 3 new cases of leukemia in the US, ...

The American Cancer Society’s estimates for acute lymphocytic leukemia (ALL) in the United States for 2025 (including both children and adults) are: About 6,100 new cases of ALL (3,450 in males and ...

Introduction: There are many different chronic lymphoblastic leukemia (CLL) survival prediction models and scores. But none provide information on expression of immune-related genes in the CLL cells.